192 related articles for article (PubMed ID: 26176534)
81. Insights into the mechanism of CXCL12-mediated signaling in trophoblast functions and placental angiogenesis.
Wang L; Li X; Zhao Y; Fang C; Lian Y; Gou W; Han T; Zhu X
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):663-72. PubMed ID: 26188201
[TBL] [Abstract][Full Text] [Related]
82. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
[TBL] [Abstract][Full Text] [Related]
83. Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system.
Chiaramonte R; Colombo M; Bulfamante G; Falleni M; Tosi D; Garavelli S; De Simone D; Vigolo E; Todoerti K; Neri A; Platonova N
Int J Biochem Cell Biol; 2015 Sep; 66():134-40. PubMed ID: 26235278
[TBL] [Abstract][Full Text] [Related]
84. The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma.
Li K; Zeng X; Liu P; Zeng X; Lv J; Qiu S; Zhang P
J Inflamm Res; 2023; 16():4301-4315. PubMed ID: 37791117
[TBL] [Abstract][Full Text] [Related]
85. Targeting oral tumor microenvironment for effective therapy.
Budi HS; Farhood B
Cancer Cell Int; 2023 May; 23(1):101. PubMed ID: 37221555
[TBL] [Abstract][Full Text] [Related]
86. Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma.
Xue Y; Jiang X; Wang J; Zong Y; Yuan Z; Miao S; Mao X
Biomark Res; 2023 Jan; 11(1):2. PubMed ID: 36600313
[TBL] [Abstract][Full Text] [Related]
87. Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.
Zhao R; Liu J; Li Z; Zhang W; Wang F; Zhang B
Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893797
[TBL] [Abstract][Full Text] [Related]
88. IL-1/IL-1R Signaling in Head and Neck Cancer.
Niklander SE; Murdoch C; Hunter KD
Front Oral Health; 2021; 2():722676. PubMed ID: 35048046
[TBL] [Abstract][Full Text] [Related]
89. Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential.
Niklander SE
Front Oral Health; 2021; 2():642238. PubMed ID: 35047997
[TBL] [Abstract][Full Text] [Related]
90. Cancer-Associated Stromal Cells Promote the Contribution of MMP2-Positive Bone Marrow-Derived Cells to Oral Squamous Cell Carcinoma Invasion.
Oo MW; Kawai H; Takabatake K; Shan Q; Eain HS; Sukegawa S; Nakano K; Nagatsuka H
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008304
[TBL] [Abstract][Full Text] [Related]
91. IL-1
Nie H; An F; Mei J; Yang C; Zhan Q; Zhang Q
Stem Cells Int; 2020; 2020():1498315. PubMed ID: 32724311
[TBL] [Abstract][Full Text] [Related]
92. Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3/NF-κB pathway.
Qin W; Li J; Zhu R; Gao S; Fan J; Xia M; Zhao RC; Zhang J
Aging (Albany NY); 2019 Dec; 11(23):11391-11415. PubMed ID: 31811815
[TBL] [Abstract][Full Text] [Related]
93. Audiometric notch for the prediction of early occupational hearing loss and its association with the interleukin-1beta genotype.
Amer NM; Taha MM; Ibrahim KS; Abdallah HM; El Tahlawy EM
J Taibah Univ Med Sci; 2019 Jun; 14(3):289-294. PubMed ID: 31435419
[TBL] [Abstract][Full Text] [Related]
94. A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab.
Espinosa-Cotton M; Fertig EJ; Stabile LP; Gaither-Davis A; Bauman JE; Schmitz S; Gibson-Corley KN; Cheng Y; Jensen IJ; Badovinac VP; Laux D; Simons AL
Biomark Res; 2019; 7():14. PubMed ID: 31346466
[TBL] [Abstract][Full Text] [Related]
95. IL-1α and IL-1β promote NOD2-induced immune responses by enhancing MAPK signaling.
Li S; Deng P; Wang M; Liu X; Jiang M; Jiang B; Yang L; Hu J
Lab Invest; 2019 Sep; 99(9):1321-1334. PubMed ID: 31019287
[TBL] [Abstract][Full Text] [Related]
96. Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma.
Porcheri C; Meisel CT; Mitsiadis T
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917608
[TBL] [Abstract][Full Text] [Related]
97. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
Espinosa-Cotton M; Rodman Iii SN; Ross KA; Jensen IJ; Sangodeyi-Miller K; McLaren AJ; Dahl RA; Gibson-Corley KN; Koch AT; Fu YX; Badovinac VP; Laux D; Narasimhan B; Simons AL
J Immunother Cancer; 2019 Mar; 7(1):79. PubMed ID: 30890189
[TBL] [Abstract][Full Text] [Related]
98. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
[TBL] [Abstract][Full Text] [Related]
99. IL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation.
Cai K; Wang B; Dou H; Luan R; Bao X; Chu J
Oncol Lett; 2017 Jun; 13(6):4238-4244. PubMed ID: 28588706
[TBL] [Abstract][Full Text] [Related]
100. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.
Petruzzi MN; Cherubini K; Salum FG; de Figueiredo MA
Diagn Pathol; 2017 Apr; 12(1):32. PubMed ID: 28381274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
